Search Results - "Waldner, Anne"
-
1
Uncontrolled Viral Replication as a Risk Factor for Non-AIDS Severe Clinical Events in HIV-Infected Patients on Long-Term Antiretroviral Therapy: APROCO/COPILOTE (ANRS CO8) Cohort Study
Published in Journal of acquired immune deficiency syndromes (1999) (01-08-2009)“…OBJECTIVE:To determine risk factor for non-AIDS severe clinical events in HIV-infected patients on long-term combination antiretroviral therapy (cART)…”
Get full text
Journal Article -
2
Incidence of and Risk Factors for Adverse Drug Reactions in a Prospective Cohort of HIV-Infected Adults Initiating Protease Inhibitor—Containing Therapy
Published in Clinical infectious diseases (15-07-2004)“…Risk factors associated with the occurrence of protease inhibitor (PI)—related severe and serious adverse drug reactions (SADRs) were analyzed in a prospective…”
Get full text
Journal Article -
3
Hepatitis B or Hepatitis C Virus Infection Is a Risk Factor for Severe Hepatic Cytolysis after Initiation of a Protease Inhibitor-Containing Antiretroviral Regimen in Human Immunodeficiency Virus-Infected Patients
Published in Antimicrobial Agents and Chemotherapy (01-12-2000)“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
4
Nocturnal hypertension in primary care patients with high office blood pressure: A regional study of the MAPAGE project
Published in The journal of clinical hypertension (Greenwich, Conn.) (01-06-2020)“…Nocturnal hypertension (NH) is an independent cardiovascular risk factor. We aimed to describe the frequency of NH among primary care hypertensive patients and…”
Get full text
Journal Article -
5
Duration of first-line antiretroviral therapy in HIV-infected treatment-naive patients in routine practice
Published in Antiviral therapy (01-01-2016)“…First-line antiretroviral therapy (1st ART) is an important step in a patient's management and often considered a long-term therapy at treatment initiation. To…”
Get more information
Journal Article -
6
Does hepatitis C virus co-infection accelerate clinical and immunological evolution of HIV-infected patients?
Published in AIDS (London) (05-03-1998)“…To study the influence of hepatitis C virus (HCV) co-infection on clinical and immunological evolution of HIV-infected patients. A longitudinal study of…”
Get full text
Journal Article -
7
Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients
Published in AIDS (London) (01-07-1994)“…To investigate (1) the frequency of clinical resistance to oral polyenes or azole treatment for oral candidiasis, (2) the frequency of resistant in vitro…”
Get more information
Journal Article -
8
Perinatal pharmacokinetics of zidovudine
Published in The New England journal of medicine (30-11-1989)Get more information
Journal Article -
9
Presence of numerous stop codons in HIV-1 reverse transcriptase proviral DNA sequences from patients with virological response to HAART
Published in AIDS (London) (12-06-2006)“…The impact of proviral DNA reverse transcriptase mutations on virological failure was evaluated in 50 HIV-1 HAART-treated patients switching from a protease…”
Get full text
Journal Article -
10
Abbreviated schedule for rabies postexposure prophylaxis
Published in The Lancet (British edition) (16-06-1990)Get more information
Journal Article -
11
Five versus ten days treatment of streptococcal pharyngotonsillitis: a randomized controlled trial comparing cefpodoxime proxetil and phenoxymethyl penicillin
Published in Scandinavian journal of infectious diseases (1994)“…A total of 220 adults and children > 10 years old (mean 29.5 +/- 11.7 years) with pharyngitis/tonsillitis were randomized to receive either cefpodoxime…”
Get more information
Journal Article